Non-alcoholic fatty liver disease: further expression of the metabolic syndrome

J Gastroenterol Hepatol. 2007 Mar;22(3):293-303. doi: 10.1111/j.1440-1746.2007.04824.x.

Abstract

Non-alcoholic fatty liver disease has been associated with metabolic disorders, including central obesity, dyslipidemia, hypertension and hyperglycemia. Metabolic syndrome, obesity, and insulin resistance are major risk factors in the pathogenesis of non-alcoholic fatty liver disease. Non-alcoholic fatty liver disease refers to a wide spectrum of liver damage, ranging from simple steatosis to non-alcoholic steatohepatitis, advanced fibrosis and cirrhosis.

Publication types

  • Review

MeSH terms

  • Animals
  • Fatty Liver / epidemiology
  • Fatty Liver / etiology*
  • Fatty Liver / therapy
  • Humans
  • Insulin Resistance
  • Metabolic Syndrome / complications*
  • Prevalence